N/A N=50 Diagnostic

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

Diabetes Mellitus

Bottom Line

View on ClinicalTrials.gov: NCT02916563 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2020

Primary outcome: Primary: Number of Successful Glucose Readings — 449 Number of Glucose readings in range

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Blood Glucose Monitoring System Altitude Performance (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: LabStyle Innovations Ltd.
Primary completion: Jul 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Successful Glucose Readings	449	—

Summary

This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).

Eligibility Criteria

Inclusion Criteria

Able to speak and read English

Exclusion Criteria

Pregnant
Has any condition that the principle investigator believes may interfere in the subject's participation in the trial.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02916563). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.